Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD

Size: px
Start display at page:

Download "Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD"

Transcription

1 Recombinant Activated Factor VII: Useful Department of Surgery Grand Rounds 11/8/10 David Mauchley MD

2 Hemostasis and Coagulation Traditional cascade model Two convergent pathways Series of proteolytic reactions Models PT (extrinsic) PTT (intrinsic) Cells to provide phospholipids (PTS)

3 Problems with Cascade Model Lack of factors VIII/IX in hemophiliacs Extrinsic production of Xa insufficient Deficiency of factor XII No bleeding despite elevated PTT Variability in bleeding severity Factor VIII/IX deficiency worse than XI Led to description of cell-based model

4 Cell-Based Model Concept that coagulation controlled by cellular components rather than proteins (factors) Occurs in three overlapping phases Tissue factor-bearing cells/platelets at center VIIa/TF complex initial step toward formation of clot Hoffman, et al. Throm Haemost. 2001

5 Recombinant Factor VIIa (rfviia) Developed in 1983 Hemophilia A FDA approval: 1999: bleeding in hemophiliacs 2005: surgery in hemophiliacs/factor VII deficiency Off-label uses Al-Ruzzeh et al. J Am Coll Surg. 2009

6 rfviia Considerations Pharmacologic doses 100x physiologic TF-dependent mechanism Factor X activation thrombin platelet activation Similar to natural factor VII TF-independent mechanism Binds activated platelets factor X activation without TF increased thrombin Ability to bypass factors VIII and IX in hemophiliacs Downregulate fibrinolytic system thrombin activation fibrinolysis inhibitor Very potent coagulant Al-Ruzzeh et al. J Am Coll Surg. 2009

7 Off-Label Use of rfviia Interest after report of treatment in trauma 1 19 yo male soldier, GSW to IVC, diffuse bleeding after repair of vessel, 60 µg/kg dose x 2 Report of success in treating post-surgical abdominal hemorrhage 2 2 pts who both underwent colectomy for GI bleed associated with Crohns both given 90 µg/kg dose x 2 1. Kenet G. Lancet White B. Br J Haematol. 1999

8 Off-Label Use of rfviia Trauma 40% early deaths related to massive bleeding Cardiac Surgery Coagulopathy after cardiopulmonary bypass (CPB) Liver Transplantation Coagulopathy due to non-functioning liver

9 Rizoli et al. J Trauma Retrospective review 242 pts 8 units PRBCs 12 hrs rfviia (38) vs. none (204) rfviia pts: Younger More penetrating trauma Lower platelets More acidotic Requiring more blood initially Trauma

10 Rizoli et al Multivariate analysis: Adjust for age, head injury score (AIS), ph Pts in rfviia group had higher predicted 24-hour survival and a trend toward overall survival

11 Trauma: Military Experience Spinella et al. J Trauma Retrospective review admissions to combat hospital Dec 2003-Oct 2005 Elevated Injury Severity Score (>15) Massive transfusion ( 10 units PRBCs) 124/5,293 pts met qualifications 49 pts rfviia (40%)

12 Mortality decreased at: 12 hrs: (p=0.008) 6/49 (12%) rfviia+ 25/75 (33%) rfviia- 24 hrs: (p=0.01) 7/49 (14%) rfviia+ 26/75 (35%) rfviia- 30 days: (p=0.03) 15/49 (31%) 38/75 (51%) Trend toward fewer pts dying of hemorrhage Spinella et al

13 Trauma: RCT Two parallel studies: Blunt/penetrating trauma Multicenter: 32 hospitals worldwide Massive transfusion (>6 units PRBC in 4hrs) 3 doses rfviia or placebo Immediately after 8 th unit, 1hr and 3hrs after first dose 200 µg/kg, 100 µg/kg, 100 µg/kg Endpoints: transfusion requirements, mortality, serious outcomes Boffard et al. J Trauma. 2005

14 Trauma: RCT Results Boffard et al. J Trauma. 2005

15 Trauma: RCT Results PRBC transfusion requirements: Need for massive transfusion: Alive at 48 hrs >20 units Blunt NNT=5.4 Boffard et al. J Trauma. 2005

16 Trauma: RCT Results Adverse Events: Essentially equal Boffard et al. J Trauma. 2005

17 Trauma: Summary Retrospective studies suggest lower mortality with rfviia in military and civilian settings Prospective RCT suggest decrease in number of RBC transfusions No difference in thromboembolic events

18 Cardiac Surgery McCall et al 2006 Retrospective review post-cpb bleeding preventing chest closure 53 pts Valve or aortic surgery Median CPB=266 min Compared transfusion before and after rfviia Decrease significant for all types of products p<0.001 McCall et al. Can J Anesth. 2006

19 Cardiac Surgery: RCT Randomized double-blind placebo trial 24 consecutive pts. complicated cardiac surgery, 5 excluded 9 pts rfviia, 10 pts placebo 90 µg/kg dose given at termination of CBP Pts taken to ICU RBC transfused for Hgb<8.5 FFP, plt, cryo given per protocol Diprose et al. Br J Anaesth. 2005

20 Cardiac Surgery: RCT Results: Placebo group: 8 pts transfused total of 105 units rfviia group: 2 pts transfused total of 13 units No difference: Hospital length of stay Vent days ICU days Thromboembolic events Diprose et al. Br J Anaesth. 2005

21 Liver Transplant Randomized, placebocontrolled, DB trial Childs class B & C- transplant for cirrhosis rfviia: 60 µg/kg or 120 µg/kg Endpoint: # of units transfused at operation Lodge et al. Liver Transplantation. 2005

22 Liver Transplant

23 Liver Transplant Results: No difference in number of transfusions Fewer pts transfused in rfviia group No difference in adverse outcomes Thromboembolic events

24 Review of 35 RCT trials 26 involving pts with varying clinical conditions (n=4119) 9 involving healthy volunteers (n=349) Thromboembolic events evaluated

25 Levi et al

26 Levi et al

27 Summary rfviia is a potent procoagulant Use of rfviia leads to decreased number of transfusions in trauma, cardiac surgery, and liver transplantation There is the suggestion of improved mortality in battlefield trauma with rfviia use rfviia is safe to use in surgical patients

Recombinant Activated Factor VII in Controlling Bleeding in Non-Hemophiliac Patients

Recombinant Activated Factor VII in Controlling Bleeding in Non-Hemophiliac Patients Bahrain Medical Bulletin, Vol. 34, No. 3, September 2012 Recombinant Activated Factor VII in Controlling Bleeding in Non-Hemophiliac Patients Ali A Faydhi, MRCP, EDIC* Adel M Al-Shabassy, MD** Yasser A

More information

Resuscitation Update

Resuscitation Update Resuscitation Update? Dr. Edward Pyun Jr., M.D. FACS Trauma Medical Director/Surgical ICU Director OSF St. Anthony Medical Center Trauma Services Perryville Surgical Associates November 10, 2012 2009 Recommendations

More information

Coagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine

Coagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine Coagulopathy: Measuring and Management Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine No Financial Disclosures Objectives Define coagulopathy of trauma Define

More information

Prothrombin Complex Concentrate- Octaplex. Octaplex

Prothrombin Complex Concentrate- Octaplex. Octaplex Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation

More information

Emergency Blood and Massive Transfusion: The Surgeon s Perspective. Transfusion Medicine Update September 16 17, 2009

Emergency Blood and Massive Transfusion: The Surgeon s Perspective. Transfusion Medicine Update September 16 17, 2009 Transfusion Medicine Update September 16 17, 2009 Mandip S. Atwal, D.O. FACOS Carl M. Pesta, D.O. FACOS Agenda History Hemorrhagic shock Transfusion is Bad Transfusion Prevention Transfusion The Red Chest

More information

Intraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL

Intraoperative haemorrhage and haemostasis. Dr. med. Christian Quadri Capoclinica Anestesia, ORL Intraoperative haemorrhage and haemostasis Dr. med. Christian Quadri Capoclinica Anestesia, ORL Haemostasis is like love. Everybody talks about it, nobody understands it. JH Levy 2000 Intraoperative Haemorrhage

More information

Shock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery

Shock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery Shock and Resuscitation: Part II Patrick M Reilly MD FACS Professor of Surgery Trauma Patient 1823 / 18 Police Dropoff Torso GSW Lower Midline / Right Buttock Shock This Monday Trauma Patient 1823 / 18

More information

TXA. Things Change. Tranexamic Acid TXA. Resuscitation 2017 TXA In The ED March 31, MAST Trousers. High Flow IV Fluids.

TXA. Things Change. Tranexamic Acid TXA. Resuscitation 2017 TXA In The ED March 31, MAST Trousers. High Flow IV Fluids. Resuscitation 2017 In The ED March 31, 2017 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN SECURE THE ABC S MAST

More information

Review of the TICH-2 Trial

Review of the TICH-2 Trial Review of the TICH-2 Trial Mikaela Hofer, PharmD PGY-1 Pharmacy Resident Pharmacy Grand Rounds September 18, 2018 2018 MFMER slide-1 Objectives Review the pharmacologic options to limit hematoma expansion

More information

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):

More information

Recombinant Factor VIIa for Intracerebral Hemorrhage

Recombinant Factor VIIa for Intracerebral Hemorrhage Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage

More information

HEMOSTASIS AND LIVER DISEASE. P.M. Mannucci. Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy

HEMOSTASIS AND LIVER DISEASE. P.M. Mannucci. Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy HEMOSTASIS AND LIVER DISEASE P.M. Mannucci Scientific Direction, IRCCS Ca Granda Foundation Maggiore Hospital, Milan, Italy 1964 ACQUIRED HEMOSTASIS DISORDERS: LIVER DISEASE Severe liver disease not uncommonly

More information

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital What do you do when the bleeding won t stop? Teddie Tanguay RN, MN, NP, CNCC(c) Teddie Tanguay RN, MN, NP, CNCC(c) Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital Outline Case study Normal coagulation

More information

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD Massive Transfusion MPQC Spring Summit April 29, 2015 Roger Belizaire MD PhD Take home points 1. Blood is always available. Requests for massive transfusion or emergency release typically only require

More information

Recombinant factor VIIa: Hype or hope? Jed Gorlin MD, MBA

Recombinant factor VIIa: Hype or hope? Jed Gorlin MD, MBA Recombinant factor VIIa: Hype or hope? Jed Gorlin MD, MBA Goals of presentation Challenge current use of rviia using data Review how rviia works Approved indications Review results of randomized trials

More information

Hemostatic Resuscitation in Trauma. Joanna Davidson, MD 6/6/2012

Hemostatic Resuscitation in Trauma. Joanna Davidson, MD 6/6/2012 Hemostatic Resuscitation in Trauma { Joanna Davidson, MD 6/6/2012 Case of HM 28 yo M arrives CCH trauma bay 5/27/12 at 241 AM Restrained driver in low speed MVC after getting shot in the chest Arrived

More information

Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery

Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery The Journal of ExtraCorporeal Technology Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery Scott D. Niles, BA, CCP;* Harold M. Burkhart, MD;* David A. Duffey, BS, BSN, CCP;* Keri

More information

Transfusion in major bleeding: new insights. Gert Poortmans

Transfusion in major bleeding: new insights. Gert Poortmans Transfusion in major bleeding: new insights Gert Poortmans Trauma Cardiac Surgery Major Surgery with ongoing blood loss Burn Surgery Lethal Triad Polytransfusion: definitions Coagulation Coagulopathy of

More information

VanderbiltEM.com. Prehospital STEMIs. EMS Today 2018 Research That Should Be On Your Radar Screen 3/1/2018

VanderbiltEM.com. Prehospital STEMIs. EMS Today 2018 Research That Should Be On Your Radar Screen 3/1/2018 EMS Today 2018 Research That Should Be On Your Radar Screen Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN VanderbiltEM.com

More information

2 Liters. Goal: Basic Algorithm Volume Resuscitation in Trauma. Initial Fluids. Blood. Where do Blood Products Come From?

2 Liters. Goal: Basic Algorithm Volume Resuscitation in Trauma. Initial Fluids. Blood. Where do Blood Products Come From? Goal: Basic Algorithm Volume Resuscitation in Trauma Sanjay Arora MD Associate Professor of Emergency Medicine Keck School of Medicine at USC Los Angeles County + USC Medical Center May 23, 2012 Initial

More information

TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage

TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage Kevin Fleming, CCP; Roberta E. Redfern, PhD; Rebekah L. March, MPH; Nathan Bobulski, CCP; Michael Kuehne, PhD, PA-C; John

More information

Introduction to coagulation and laboratory tests

Introduction to coagulation and laboratory tests Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises

More information

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive transfusion: Recent advances, guidelines & strategies Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive Hemorrhage Introduction Hemorrhage is a major cause

More information

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial

More information

Hemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands

Hemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins

More information

Recombinant Factor VIIa in Pediatric Patients

Recombinant Factor VIIa in Pediatric Patients ( TATM 2003;5(5 Suppl):40-45 Recombinant Factor VIIa in Pediatric Patients JOSEPH D. TOBIAS, MD VICE-CHAIRMAN, DEPARTMENT OF ANESTHESIOLOGY CHIEF, PEDIATRIC CRITICAL CARE/PEDIATRIC ANESTHESIOLOGY RUSSELL

More information

Hemostatic Resuscitation

Hemostatic Resuscitation Hemostatic Resuscitation 30 th David Miller Trauma Symposium Bill Beck, MD Assistant Professor of Surgery Trauma, Emergency General Surgery, Critical Care Disclosures None Again. Mac user. Why I Like Trauma?

More information

Kay Barrera MD. Surgery Grand Rounds June 19, 2014 SUNY Downstate

Kay Barrera MD. Surgery Grand Rounds June 19, 2014 SUNY Downstate Kay Barrera MD Surgery Grand Rounds June 19, 2014 SUNY Downstate Kay Barrera MD Surgery Grand Rounds June 19, 2014 SUNY Downstate Outline Why are we talking about this SCORE expectations When do we use

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard The principle of 1:1:1 blood product use in the resuscitation of trauma victims K. D. Boffard Milpark Hospital Department of Surgery University of the Witwatersrand Johannesburg, South Africa Annual Controversies

More information

Part IV Antithrombotics, Anticoagulants and Fibrinolytics

Part IV Antithrombotics, Anticoagulants and Fibrinolytics Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System

More information

Hydroxyethyl starch and bleeding

Hydroxyethyl starch and bleeding Hydroxyethyl starch and bleeding Anders Perner Dept. of Intensive Care, Rigshospitalet University of Copenhagen Scandinavian Critical Care Trials Group Intensive Care Medicine COIs Ferring, LFB - Honoraria

More information

Epidemiology. Case. Pre-Hospital SI and Massive Transfusion

Epidemiology. Case. Pre-Hospital SI and Massive Transfusion Epidemiology Preston Maxim, MD Assoc. Professor of Emergency Medicine San Francisco General Hospital ~180,000 deaths 2007 due to trauma 25% trauma patients require 1 unit of PRBC and only 25% of those

More information

2012, Görlinger Klaus

2012, Görlinger Klaus Gerinnungsmanagement der Gegenwart - wie gehen wir heute vor? 25. Allander Gerinnungsrunde am 15. März 2012 Klaus Görlinger Universitätsklinikum Essen klaus@goerlinger.net CSL Behring GmbH Octapharma AG

More information

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow

More information

Coagulation, Haemostasis and interpretation of Coagulation tests

Coagulation, Haemostasis and interpretation of Coagulation tests Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect

More information

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015 Management of the Trauma Patient Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015 Saturday Night 25 yo M s/p high speed MVC Hypotensive in the ED, altered

More information

Clinical Overview of Coagulation Testing Issues

Clinical Overview of Coagulation Testing Issues Clinical Overview of Coagulation Testing Issues Adam M. Vogel, MD Assistant Professor, Division of Pediatric Surgery Washington University in St. Louis School of Medicine September 19, 2014 Disclosure

More information

Chapter 1 Introduction

Chapter 1 Introduction Chapter 1 Introduction There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep

More information

How can ROTEM testing help you in cardiac surgery?

How can ROTEM testing help you in cardiac surgery? How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential

More information

L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche

L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University

More information

Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out?

Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out? Pre-hospital Administration of Blood Products (PHBP) and Tranexamic acid (TXA): Is the Jury Still Out? Jessica K. Reynolds, MD Assistant Professor of Surgery University of Kentucky, Department of Trauma

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

10/4/2018. Nothing to Disclose. Liz Robertson, MD FACS October 5, 2018 Steven R. Hall Trauma Symposium Big Cedar Lodge, MO

10/4/2018. Nothing to Disclose. Liz Robertson, MD FACS October 5, 2018 Steven R. Hall Trauma Symposium Big Cedar Lodge, MO Nothing to Disclose Liz Robertson, MD FACS October 5, 2018 Steven R. Hall Trauma Symposium Big Cedar Lodge, MO History of IV Resuscitation Review of Data for Fluid Strategies Historical Examples of IV

More information

3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic?

3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic? Abigail E. Miller, PharmD, BCPS Clinical Specialist, Cardiology University of North Carolina Hospitals I have no personal financial relationships with the manufacturers of the products to disclose. Boehringer

More information

The changing face of massive transfusion

The changing face of massive transfusion The changing face of massive transfusion HAABB, Kansas City, 18 April 2018 John R. Hess, MD, MPH, FACP, FAAAS Professor of Laboratory Medicine Medical Director, Transfusion Service, Harborview MC U of

More information

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:

More information

Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery

Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Butler Journal of Undergraduate Research Volume 2 Article 24 2016 Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Lisa K. LeCleir Butler University, lisa.lecleir@gmail.com

More information

Primary Exam Physiology lecture 5. Haemostasis

Primary Exam Physiology lecture 5. Haemostasis Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation

More information

Financial Disclosure. Objectives 9/24/2018

Financial Disclosure. Objectives 9/24/2018 Hemorrhage and Transfusion Adjuncts in the Setting of Damage Control Joseph Cuschieri, MD FACS Professor of Surgery, University of Washington Adjunct Professor of Orthopedics and Neurosurgery, University

More information

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes

More information

Managing Bleeding in the Patient on DOACs

Managing Bleeding in the Patient on DOACs Managing Bleeding in the Patient on DOACs Spring 2016 Jean M. Connors, MD Anticoagulation Management Services BWH/DFCI Hemostatic Antithrombotic Stewardship BWH Assistant Professor of Medicine, HMS Conflicts

More information

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference John A. Aucar, MD, MSHI, FACS, CPE EmCare Acute Care Surgery Del Sol Medical Center Associate Professor, University

More information

Contents. What is NovoSeven? Current Indication. How does NovoSeven work? Clinical settings under investigation. Trauma Study. ICH Study.

Contents. What is NovoSeven? Current Indication. How does NovoSeven work? Clinical settings under investigation. Trauma Study. ICH Study. Update on NovoSeven Contents What is NovoSeven? Current Indication How does NovoSeven work? Clinical settings under investigation Trauma Study ICH Study The Registry What is NovoSeven? A recombinant coagulation

More information

Bleeding and Management of Coagulopathy

Bleeding and Management of Coagulopathy Bleeding and Management of Coagulopathy Jerrold H. Levy, MD, FAHA Professor of Anesthesiology Deputy Chair for Research Emory University School of Medicine Director, Cardiothoracic Anesthesiology CT Anesthesiology

More information

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components Objectives Transfusion Pitfalls Gregory W. Hendey, MD, FACEP Professor and Chief UCSF Fresno, Emergency Medicine To list risks and benefits of various blood products To discuss controversy over liberal

More information

4/23/2009. September 15, 2008

4/23/2009. September 15, 2008 The Current Treatment of Deep Venous Thrombosis: Are We Doing Enough? George H. Meier, MD Professor and Chief Division of Vascular Surgery University of Cincinnati College of Medicine Cincinnati, Ohio

More information

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013 General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding

More information

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences

More information

Coagulopathy Case - 3. Andy Nguyen, M.D. 2009

Coagulopathy Case - 3. Andy Nguyen, M.D. 2009 Coagulopathy Case - 3 Andy Nguyen, M.D. 2009 CLINICAL HISTORY A 21 year-old male seen in the emergency room with a swollen, tender right knee. Patient is an electrician who had fallen to the ground an

More information

EXCESSIVE BLEEDING IS A common complication of

EXCESSIVE BLEEDING IS A common complication of The Utility of Thromboelastography for Guiding Recombinant Activated Factor VII Therapy for Refractory Hemorrhage After Cardiac Surgery Marcin Wąsowicz, MD,* Massimiliano Meineri, MD,* Stuart M. McCluskey,

More information

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation

More information

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot Hemostasis Clo)ng factors and Coagula4on Dr Badri Paudel www.badripaudel.com Hemostasis is defined as a property of circula4on whereby blood is maintained within a vessel and the ability of the system

More information

Groupe d Intérêt en Hémostase Périopératoire

Groupe d Intérêt en Hémostase Périopératoire How do I treat massive bleeding? Red blood cell / plasma / platelet ratio and massive transfusion protocols Anne GODIER Service d Anesthésie-Réanimation Hopital Cochin Paris Groupe d Intérêt en Hémostase

More information

Damage Control Resuscitation. VGH Trauma Rounds 2018 Harvey Hawes

Damage Control Resuscitation. VGH Trauma Rounds 2018 Harvey Hawes Damage Control Resuscitation VGH Trauma Rounds 2018 Harvey Hawes Example Case 25yo F in motor vehicle collision at high speed Picked up at scene by Helicopter EMS unit Initial vital signs: HR 134 BP 88/42

More information

Thicker than Water. Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago

Thicker than Water. Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago Thicker than Water Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago I have no relevant financial relationships to disclose. Who is bleeding? How much and what kind

More information

Challenges in Coagulation

Challenges in Coagulation Challenges in Coagulation Michael H. Rosove, MD Clinical Professor of Medicine UCLA Division of Hematology-Oncology April 30, 2016 Vitamin K Deficiency Vitamin K1 source from diet Vitamin K2 source from

More information

Evaluation of Off-Label Recombinant Activated Factor VII for Multiple Indications in Children

Evaluation of Off-Label Recombinant Activated Factor VII for Multiple Indications in Children Evaluation of Off-Label Recombinant Activated Factor VII for Multiple Indications in Children Pamela D. Reiter, PharmD, * Robert J. Valuck, PhD, RPh, and Ruston S. Taylor, PharmD * Pediatric ICU and Trauma,

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

Managing Hemostasis in Trauma

Managing Hemostasis in Trauma Managing Hemostasis in Trauma Acute of Trauma/Shock NovoSeven Efficacy and Risk Cyclokapron (tranexamic acid) George A. Fritsma, MS MT (ASCP) fritsmafactor.com; george@fritsmafactor.com Death by Trauma:

More information

New Age Anticoagulants: Bleeding Considerations

New Age Anticoagulants: Bleeding Considerations Ontario Regional Blood Coordinating Network March 23, 2012 New Age Anticoagulants: Bleeding Considerations Bill Geerts, MD, FRCPC Thromboembolism Specialist, Sunnybrook HSC Professor of Medicine, University

More information

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation

More information

5/30/2013. I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow. Trauma = #1 cause of death persons <40 yo 1

5/30/2013. I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow. Trauma = #1 cause of death persons <40 yo 1 I have no conflicts of interest to disclose. Alicia Privette, MD Trauma & Critical Care Fellow Trauma = #1 cause of death persons

More information

Mechanisms of Trauma Coagulopathy. Dr B M Schyma Changi General Hospital Singapore

Mechanisms of Trauma Coagulopathy. Dr B M Schyma Changi General Hospital Singapore Mechanisms of Trauma Coagulopathy Dr B M Schyma Changi General Hospital Singapore HAEMORRHAGE A continued cause of PREVENTABLE death. 24% of trauma patients are coagulopathic on arrival 1 56% of severe

More information

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Transfusion & Mortality. Philippe Van der Linden MD, PhD Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:

More information

GLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012

GLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012 GLANZMANN S THROMBASTHENIA Stacey Shiovitz January 13, 2012 HELP!! MY PATIENTHASGT DO YOU EVEN KNOW WHAT THAT IS? CASE 27yo woman presented tdto gynecology clinic i for menorrhagia x 10 days Bleeding started

More information

HEMLIBRA (emicizumab-kxwh) IN HEMOPHILIA A WITH INHIBITORS

HEMLIBRA (emicizumab-kxwh) IN HEMOPHILIA A WITH INHIBITORS HEMLIBRA (emicizumab-kxwh) IN HEMOPHILIA A WITH INHIBITORS Media Inquiries: (650) 467-6800 About HEMLIBRA HEMLIBRA (emicizumab-kxwh) is approved by the FDA as a prophylactic medicine used to prevent or

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Assessing thrombocytopenia in the intensive care unit: The past, present, and future

Assessing thrombocytopenia in the intensive care unit: The past, present, and future Assessing thrombocytopenia in the intensive care unit: The past, present, and future Ryan Zarychanski MD MSc FRCPC Sections of Critical Care and of Hematology, University of Manitoba Disclosures FINANCIAL

More information

Disclosure Chair of ACS COT EMS Committee Authored Evidence Based Prehospital Guideline for External Hemorrhage Control

Disclosure Chair of ACS COT EMS Committee Authored Evidence Based Prehospital Guideline for External Hemorrhage Control Eileen M. Bulger, MD Professor of Surgery, Chief of Trauma Harborview Medical Center University of Washington Disclosure Chair of ACS COT EMS Committee Authored Evidence Based Prehospital Guideline for

More information

Pediatric massive transfusion protocols

Pediatric massive transfusion protocols University of New Mexico UNM Digital Repository Emergency Medicine Research and Scholarship Emergency Medicine 2014 Pediatric massive transfusion protocols Ramsey Tate Follow this and additional works

More information

Damage Control in Abdominal and Pelvic Injuries

Damage Control in Abdominal and Pelvic Injuries Damage Control in Abdominal and Pelvic Injuries Raul Coimbra, MD, PhD, FACS The Monroe E. Trout Professor of Surgery Surgeon-in Chief UCSD Medical Center Hillcrest Campus Executive Vice-Chairman Department

More information

Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF

Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF Debate: New Generation Anti-Coagulation Agents are a Better Choice than Warfarin in the Management of AF Bradley P. Knight, MD Director of Cardiac Electrophysiology Bluhm Cardiovascular Institute Northwestern

More information

How can ROTEM testing help you in trauma?

How can ROTEM testing help you in trauma? How can ROTEM testing help you in trauma? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential diagnosis

More information

3/16/15. Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation. Obligatory Traumatologist Slide

3/16/15. Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation. Obligatory Traumatologist Slide Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation Courtney Sommer, MD MPH Duke Trauma Symposium March 12, 2015 Obligatory Traumatologist Slide In 2010 trauma was leading

More information

Managing Hemostasis in Trauma 7/29/11. Heat Wave of fritsmafactor.com 1. Managing Hemostasis in Trauma Acute Coagulopathy of Trauma & Shock

Managing Hemostasis in Trauma 7/29/11. Heat Wave of fritsmafactor.com 1. Managing Hemostasis in Trauma Acute Coagulopathy of Trauma & Shock Managing Hemostasis in Trauma Acute of Trauma & Shock Heat Wave of 2011 NovoSeven Efficacy and Risk Cyclokapron (tranexamic acid) George A. Fritsma, MS MLS fritsmafactor.com; george@fritsmafactor.com 1

More information

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist Pharmacy Grand Rounds 26 July 2016 2015 MFMER slide-1 Learning

More information

Use of Prothrombin Complex Concentrates (PCC) CONTENTS

Use of Prothrombin Complex Concentrates (PCC) CONTENTS CONTENTS Page 1: Exclusion Criteria and Approved Indications for Use Page 2: Dosing / Administration / Storage Page 4: Prescribing / Monitoring / Dispensing Page 5: Cautions / Warnings / Cost Analysis

More information

Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled Hemorrhage in Non-Hemophilic Patients

Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled Hemorrhage in Non-Hemophilic Patients TZU CHI MED J December 2007 Vol 19 No 4 available at http://ajws.elsevier.com/tcmj Tzu Chi Medical Journal Original Article Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled

More information

WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION

WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT ARTICLES OUR STUDY BLEEDING CONTROL 5 POINT MODEL WO NDCLOT The WoundClot Principals for Effective Bleeding Control PRESENTATION Harnessing SCIENCE

More information

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes

More information

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Massive Blood Transfusion Michael A. Belfort, MD, PhD Professor and Chairman Department of Obstetrics and Gynecology

More information

Implementation and execution of civilian RDCR programs Minnesota RDCR

Implementation and execution of civilian RDCR programs Minnesota RDCR Implementation and execution of civilian RDCR programs Minnesota RDCR Donald H Jenkins, MD FACS Associate Professor of Surgery and Director of Trauma Division of Trauma, Critical Care and Emergency General

More information

Recombinant Factor Seven Therapy for Postoperative Bleeding in Neonatal and Pediatric Cardiac Surgery

Recombinant Factor Seven Therapy for Postoperative Bleeding in Neonatal and Pediatric Cardiac Surgery Recombinant Factor Seven Therapy for Postoperative Bleeding in Neonatal and Pediatric Cardiac Surgery Hemant S. Agarwal, MBBS, Jo E. Bennett, BS, Kevin B. Churchwell, FAAP, MD, Karla G. Christian, MD,

More information

Platelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment

Platelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment Objectives IIb/IIIa, Vitamin K, and Direct Thrombin Inhibition in Cardiology Michael Gulseth, Pharm. D., BCPS Assistant Professor, Duluth Pharmacy 6122 February 14, 2005 Describe the pharmacology, kinetics,

More information

Adult Trauma Advances in Pediatrics. (sometimes they are little adults) FAST examination. Who is bleeding? How much and what kind of TXA volume?

Adult Trauma Advances in Pediatrics. (sometimes they are little adults) FAST examination. Who is bleeding? How much and what kind of TXA volume? Adult Trauma Advances in Pediatrics (sometimes they are little adults) Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago Alisa McQueen MD, FAAP, FACEP Associate

More information

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital Disseminated intravascular coagulation (DIC) Disseminated

More information

CRASH ing Trauma Patients: The CRASH trials. Tim Coats Professor of Emergency Medicine University of Leicester, UK

CRASH ing Trauma Patients: The CRASH trials. Tim Coats Professor of Emergency Medicine University of Leicester, UK CRASH ing Trauma Patients: The CRASH trials Tim Coats Professor of Emergency Medicine University of Leicester, UK www.le.ac.uk/emag I DO NOT have an affiliation (financial or otherwise) with a pharmaceutical,

More information

Damage Control Resuscitation

Damage Control Resuscitation Damage Control Resuscitation H M Cassimjee Critical Care Specialist Department of Critical Care & Level 1 Trauma Unit Inkosi Albert Luthuli Central Hospital Damage Control Resuscitation only for DAMAGED

More information

ACQUIRED COAGULATION ABNORMALITIES

ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation

More information